1. Introduction {#sec1}
===============

Scar formation strongly depends on the presence of contraction during healing and the nature of the scar is actually the uneven look of the healed tissue resulting from disfigured tissue deformation and overaligned collagen fibers \[[@B1]\]. Collagen in hypertrophic scars is found to be in a disorganized, whorl-like arrangement rather than in the normal parallel orientation manner. Therefore, hypertrophic scars are indurate, elevated, poorly extensible, and also characterized by hypervascularity, thereby providing their erythematous appearances \[[@B2]\]. HS can cause significant abnormality in aesthetic and functional symptoms and to date no recognized treatment has been established. It commonly occurs after surgical incision, thermal injury, and traumatic injuries to the dermis with a subsequent abnormal healing response \[[@B3]\]. Furthermore, it is often associated with contractures that can lead to considerably reduced functional performance in patients.

The development of antihypertrophic scars is an unsolved problem in the process of scar treatment. For this reason, some undiscovered successful treatments are needed to prevent excessive hypertrophic scarring. The reported preventions include topical medical application, cryotherapy, use of silicone gel sheets, injection of steroids, radiotherapy, and an early surgical procedure for wound closure \[[@B2]\]. In the last decade, there has been a renewed interest in the use of indigenous medicine worldwide, arising from the realization that orthodox medicine is not widespread. Although modern medicine may be available in some communities, herbal medicines have often maintained popularity for historical and cultural reasons, in addition to their cheaper costs \[[@B4]\]. Recent research has introduced the uses of phytochemical compounds and extracts isolated from medicinal plants in an attempt to resolve these problems as a promising therapy.

Many treatment strategies are sought to prevent scar formation without compromising the wound healing process \[[@B5]\]. The effectiveness of currently used therapy against hypertrophic scar arises most probably from the increase of the medicinal plants reported. In the modern system of medicine, about 25% of prescriptions contain active principle(s) derived from plants \[[@B4]\]. A significant correlation between medicinal plants and their use in the treatment of many types of scars has been shown in epidemiological data generated throughout the world. Published clinical trials have, as yet, largely focused on characterizing the pharmacokinetics and metabolism of medicinal plants. Despite experimental advances in medicinal plant research against scars, findings in humans are still limited. However, in recent years, diverse benefits of medicinal plants in the treatment of hypertrophic scars have been described \[[@B6]--[@B9]\].

In line with the latest findings responsible for the increased recognition of medicinal plants as potential therapeutic and/or preventative agents, the aim of the present review is to focus on recent experimental findings and clinical trials of medicinal plants and other preparations with similar actions that could account for beneficial effects on hypertrophic scars in patients. Natural products, such as plant extracts, either as pure compounds or as standardized extracts, provide unlimited opportunities for control of hypertrophic scarring owing to their chemical diversity \[[@B10]\]. Currently, a great deal of effort is being expended to find alternative sources of safe, effective, and acceptable natural medicinal plants for the treatment or prevention of hypertrophic scars; hence, all literature available was reviewed.

2. Suggested Mechanism of Hypertrophic Scarring {#sec2}
===============================================

The molecular mechanism of hypertrophic scarring is associated with the unusual proliferation of fibroblasts and overproduction of collagen and extracellular matrix \[[@B11]\]. An array of intra- and extracellular mechanisms is essential in the prevention of scar formation. With the help of molecular biology, cell biology technology, hypertrophic scar animal models, and the setting-up of scar tissue engineering, the mechanism of hypertrophic scarring has been clearly defined ([Figure 1](#fig1){ref-type="fig"}). It is usually considered as migration and proliferation of different cell types such as keratinocytes, myofibroblasts \[[@B12]\], and mast cells \[[@B13]\]. Fibroblasts play an essential role in new tissue formation during wound repair \[[@B14]\], but their abnormal low death rate and high proliferation rate can cause scar tissue formulation \[[@B15]\]. Meanwhile, keratinocytes are indispensable in signal transduction between paracrine secretion and epithelium matrix. When cultured in the presence of keratinocytes, fibroblasts exhibit significant proliferation activity \[[@B16]\], showing the contribution of keratinocytes to fibroblasts proliferation. Myofibroblasts, which are different from fibroblasts and are related to the composition, organization, and mechanical properties of ECM \[[@B17]\], increase collagen synthesis and retard cell migration \[[@B13]\], thus resulting in excessive and rigid scarring. Fibroblasts are transformed into myofibroblasts by heterocellular gap junction intercellular communications between mast cells (RMC-1) and fibroblasts \[[@B13], [@B18]\]. In the process of wound healing, the combination of fibroblasts and myofibroblasts triggers excessive production of abnormal extracellular matrix protein \[[@B19]\], eliciting scarring \[[@B1], [@B19]\]. With the assistance of keratinocytes and mast cells, proliferative fibroblasts produce massive collagen which makes extracellular matrix accumulate below dermis, leading to scar formation. The complex forming process consists of three different phases, inflammation, proliferation, and maturation, which leads to hypertrophic scarring in the end \[[@B20]\]. The ratio of I to III collagens in healthy adults ranges from 3.5 to 6.1, while in patients with hypertrophic scars, it could be down to 2 and in keloid patients it can be as high as 19, which is related to the abnormal metabolism of collagens I and III in pathological scars, including more collagen synthesis and less collagen degradation.

Although many targets of action, by which scarring can be inhibited, have been experimentally studied or postulated, few are well known or defined for inhibition of hypertrophic scarring by plant-derived compounds. [Figure 2](#fig2){ref-type="fig"} and Tables [5](#tab5){ref-type="table"} and [6](#tab6){ref-type="table"} summarize and enumerate the suggested mechanisms and correlative medicinal plants.

The size of a scar is influenced by many factors, such as wound size, wound contraction, and healing time. Wound contraction makes an important contribution to scar formation also the larger the area of the wound, the more cells migrate, resulting in more prominent scarring \[[@B1]\]. Therefore, induction of fibroblast apoptosis and reduction of extracellular matrix and collagen I/III production may be the pivotal measures against hypertrophic scarring.

Many kinds of test models are applied to investigate wound healing mechanisms and inhibition of scar formation, including 2D hybrid agent-based model \[[@B1]\], pig surgical injury model, fibroblast populated collagen lattice (FPCL) model, rat laminectomies at Lumbar-1 level \[[@B5]\], incisional wound healing model \[[@B6]\], and rabbit ear model \[[@B21]\]. These models provide a mean for detecting and evaluating the mechanobiology in wound healing and scar formation \[[@B1]\].

However, the complex mechanism of hypertrophic scarring still remains unknown which raises the question of how to control scar hyperplasia.

3. Medicinal Plants against Hypertrophic Scarring {#sec3}
=================================================

Many beneficial uses of medicinal plants are extensively documented in the traditional medicine systems in many cultures. To collect the data which supports this finding, we performed a systematic review using PubMed, Elsevier, Springer, and Google Scholar databases and peer-reviewed articles published in the last 10 years. The search terms included scar, scaring, fibroblast, extract, and preparation. The phytochemicals from medicinal plants against scar hyperplasia are presented in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}, respectively, whilst the medicinal plant extracts are listed in [Table 3](#tab3){ref-type="table"}. Their activities and mechanisms for antihypertrophic scarring were also described, respectively, in Tables [1](#tab1){ref-type="table"}, [2](#tab2){ref-type="table"}, and [3](#tab3){ref-type="table"}. There are five preparations ([Table 4](#tab4){ref-type="table"}) reported on their effects and mechanisms of antihypertrophic scarring, namely, liposome-encapsulated 10-HCPT, oxymatrine-phospholipid complex (OMT-PLC), solid lipid nanoparticle-enriched hydrogel (SLN-gel), Ginsenoside Rg3/poly (l-lactide) (G-Rg3/PLLA), and*Centella asiatica* extract capsule, which are composed of different medicinal plants and vehicles. Medicinal plants can be used for different therapeutic purposes or as precursors of useful drugs containing different types of phytochemicals.

The use of herbal medicine remedy has been steadily increasing worldwide in recent years, as well as the search for new phytochemicals that could be potentially developed as useful drugs for the treatment of hypertrophic scar and other scar diseases \[[@B4]\]. The antihypertrophic scar activity of medicinal plants results from a variety of components contained in these plants (Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}). Many plant extracts ([Table 3](#tab3){ref-type="table"}) have antihypertrophic scar activity owing to their phytochemical constituents. However, more work is needed to focus on purification and identification of active components and to elucidate the roles that these play in inhibition of scars when used alone or jointly. Moreover, many of them have not been tested for their cytotoxicity to normal cells, which seriously blocks*in vivo* investigations. Undeniably, no toxic and side effects have been proved for some active components. For example, Genistein, which is easily obtained and commonly used for hypertrophic scar treatment, has strong pharmacological effects, with no obvious toxicity or side effects \[[@B22]\].

4. New Preparations of Medicinal Plants {#sec4}
=======================================

A large number of extracts and compounds of medicinal plants display antiscar activity. Nevertheless, drugs are difficult to get through the stratum corneum due to the natural barrier of skin, which causes lower permeability of drugs. The oral bioavailability of drugs at the permissive dose is very low, owing to their hydrophilicity (low permeability), poor absorption, and biotransformation or compact scar tissue. The appropriate form of prepared drugs can evidently improve drug permeability, lipid solubility, skin permeability, retention ratio, release time, and cytotoxicity. Hydroxycamptothecin (HCPT) is thought to be one of the most effective components against scars. However, the poor solubility and short half-life severely limit its clinical applications \[[@B23]\]. Compared with HCPT, the liposome-encapsulated HCPT (L-HCPT) can reduce epidural fibrosis by preventing the proliferation of fibroblasts in the scar tissue with longer half-life and better solubility \[[@B23]\]. The application of a silicone derivative to herbal extracts can improve skin pliability and alleviate the concomitant symptoms of scars including pain and itching \[[@B2]\]. However, it is extremely important to control the cytotoxicity of biomaterials for their clinical applications. Microemulsion, a transparent dispersion system, is a good vehicle for drug delivery due to its many advantages such as thermodynamic stability (long shelf life), easy formation (zero interfacial tension), low viscosity, high surface area (high solubilization capacity), and small droplet size \[[@B24]\]. It has been revealed that drug-free microemulsion is a promising preparation due to inapparent cytotoxicity \[[@B24]\]. The local or transdermal application of water-soluble pharmaceutical formulation may be suitable for medicinal plant extracts and compounds.

Owing to compact scar tissue, it is necessary for the combination of natural products or crude extracts with some adjuvant as new dosage forms to increase their solubility, content, release time, uptake, and penetrability. These dosage forms include microemulsion \[[@B24]\], liposomes \[[@B25]\], solid lipid nanoparticle \[[@B26]\], and electrospun fibrous scaffolds \[[@B27]\]. Improvement of drug permeation may be a promising treatment in future research on the basis of the known medicinal plants.

In addition, some of these plant extracts or purified chemical components are prepared as traditional medicinal injections for the deep antiscar treatment. For example,*Carthamus tinctorius* injection, whose primary component is hydroxysaflor yellow A, softens hypertrophic scar tissue and inhibits fibroblast proliferation by decreasing the type I/type III collagens ratio and the TGF-*β* ~1~ level after local treatment \[[@B28]\]. The*radix astragali* injection also inhibits the proliferation and reduces scar thickness and hardness by reducing Smad3 and TGF-*β* ~1~ levels \[[@B29]\].

5. Current Treatment and Prospects for Future Therapies {#sec5}
=======================================================

Currently, occlusive dressings, compression therapy, intralesional steroid, cryosurgery, laser, radiation, surgical excision, and interferon therapy are curative for the majority of patients with hypertrophic scars \[[@B30]\]. Surgical therapy and excising fiber fraction are the common approaches for the treatment of hypertrophic scars. However, significant disadvantages were reported, such as the recurrence of adhesion after surgery as high as 45%--100% \[[@B21]\], which seriously limits its extensive application to scar prevention. Accordingly, physiotherapy is established, including occlusive dressings, pressure therapy, cryosurgery, radiation therapy, and laser therapy. Meanwhile, pharmacotherapy is also frequently applied, such as intralesional corticosteroid injection and topical drug treatment with interferon, bleomycin, 5-fluorouracil, verapamil, vitamin E, imiquimod, TGF-*β* ~3~, or interleukin-10 \[[@B30], [@B31]\]. Pharmacotherapy mainly inhibits inflammation, proliferation, and remodeling phase \[[@B7]\] or modifies ECM metabolism via interfering the pivotal molecules of MAPK, TGF-*β*, and PI3K signaling transduction.

However, there is no ideal treatment for hypertrophic scars so far and some chemical drugs also cause mal-effects simultaneously. Many kinds of natural products from medicinal plants have good antiscar activity and show notable advantages due to their fewer side-effects. Therefore, in addition to widespread uses of surgical therapy, physiotherapy, and pharmacotherapy, there is a great need for developing new natural drugs more efficient than or synergizing with the existing ones. Many kinds of purified natural products originated from medicinal plants are abundant in the natural environment, such as Ginsenoside Rg3 \[[@B27]\], Oleanolic Acid \[[@B21]\], Resveratrol \[[@B32]\], Asiaticoside \[[@B33]\], and Genistein \[[@B22]\], and are popular as antiscar agents due to their easy obtainment and fewer side-effects. Hence, we overviewed the major current herbs and their preparations applied to the treatment of hypertrophic scars.

It is a challenge to identify and evaluate a safe, wholesome, and effective natural product against scars. Even though a number of new products have been reported by pharmacological tests in the last decades, many others remain unknown or untested.

6. Discussion {#sec6}
=============

In this review, we gathered publications on medicinal plants with antihypertrophic scar activity and addressed the question whether the treatment of scars with medicinal plants is effective in humans. Although*in vivo* and*in vitro* investigations play an important role in the evaluation of safety and effectiveness of medicinal plants in preclinical trials, there is no perfect denouncement for their ultimate success as human drugs. Clearly, animal data are not sufficient for the confirmation of the safety and efficacy of medicinal plants in humans owing to their physiological structure differences. Furthermore, there are some conflicting clinical trials reported. For example, it has been reported that honey was effective in rapidly cleaning infection and promoting wound healing, indicating that honey possessed anti-infection activity \[[@B34]\]. However, it was also reported that honey did not affect the wound, scar, length, and remained length \[[@B35]\]. Therefore, the effectiveness of some drugs needs to be further clarified.

On the other hand, only four publications reported negative results in our retried papers. Genistein phosphorylated c-Raf, MEK1/2, ERK1/2, and p38 proteins, but not JNK protein \[[@B36]\]. Asiaticoside had no effect on the expression of Smad2, Smad3, and Smad4 \[[@B33]\], while madecassoside regulated keloid-derived fibroblasts proliferation, migration, F-actin filaments, cytoskeletal protein actin, and the phosphorylation of cofilin via p38 MAPK and PI3K/AKT signaling, but not ERK1/2 and caspase-8 signaling \[[@B37]\]. Quercetin promoted phosphorylation of JNK and ERK, but not p38; it increased the protein and mRNA expression of MMP-1, but not type I collagen and TIMP-1 \[[@B38]\]. These studies indicate that the antiscar activity of medicinal plants needs to be scrutinized further.

Many traditional medicines used in folk medicine are reported to have antiscar activity, but only a few have been studied systematically*in vitro* or/and*in vivo*, such as rhubarb \[[@B39]\] and tamarind \[[@B40]\]. Although numerous*in vitro*studies have substantiated the antiscar activity of plant extracts and phytochemicals, there is very little evidence in humans. The number of clinical trials and their highlighted results are limited. The numerous traditional formulations effectively and extensively used in clinics have not been investigated. Also, the majority of the plants (Tables [1](#tab1){ref-type="table"}, [2](#tab2){ref-type="table"}, and [3](#tab3){ref-type="table"}) traditionally used as antiscar agents have not been investigated in animals. The phytochemicals with*in vitro* antiscar activity may have no effects*in vivo* due to the exceedingly high doses. Moreover, many of these phytochemicals have not been tested for their cytotoxicity, acute toxicity, or/and long-term toxicity in normal cells and animals, which seriously limits*in vivo* investigations. Only two medicinal plants have been reported on their untoward reactions and cytotoxic effects. The clinical efficacy and safety should be investigated simultaneously for medicinal plant extracts and compounds.

The natural barrier of skin can block drug getting through stratum corneum or decrease the amount of drug permeation, causing inefficiency or low-efficiency of drugs. Some adjuvants can significantly improve the penetrability of drugs and the desired therapeutic effects can be achieved. For example, hydroxycamptothecin (HCPT) is considered one of the most effective agents against scars, which prevents fibroblast proliferation and reduces epidural adhesion, but the poor solubility and short half-life severely limits its clinical application \[[@B23]\]. Some new dosage forms evidently reverse these conditions, such as microemulsion \[[@B24]\], liposomes \[[@B25]\], solid lipid nanoparticle \[[@B26]\], and electrospun fibrous scaffolds \[[@B27]\]. Therefore, the development of new dose types is necessary in order to ameliorate drug effects.

Although enormous progress has been achieved over the last years, the impact of medicinal plants on individual types of scars needs to be explored in more detail. Polymechanistic phytochemicals such as Genistein may have an advantage over targeted therapeutics, which simultaneously tackle scar treatment from multiple angles. Genistein can act on many target points, including suppression of PDGF-promoted TPK activation, decrease of types I/III precollagen and PCNA expression, reduction of c-Raf, MEK1/2, ERK1/2, and p38 protein phosphorylation, and inhibition of RTK-Ras-MAPK (ERK/p38) \[[@B22]\]. Further insights into the molecular mechanisms of phytochemicals will facilitate the development of new drugs for the prevention and treatment of human scars.

7. Conclusion {#sec7}
=============

In conclusion, the scaring process is complicated. The characteristics of an appropriate therapy for the prevention and treatment of scars should comprise the following: simple and easy delivery, comparability (effectiveness) with current therapies, and minimal drug interaction with concomitant treatments and lack of significant side effects \[[@B42]\]. Manyextracts and compounds from medicinal plants can inhibit scarring. The main mechanisms are suppression of proliferation and/or induction of apoptosis in scar fibroblasts by regulation of several pathways, such as MAPK, PI3K/AKT, RhoA/ROCK-I, VEGF, FAK, and TGF-*β*/Smad. Although the approaches described here are quite different and mechanisms are complicated, the utility should be maximized for medicinal plants as antihypertrophic scar agents. However, screening is necessary to minimize any potentially harmful side effects on human skin and health.
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###### 

The components from medicinal plants with antihypertrophic scar activity.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Component                 Botanical name                                                                                                                                                                                                                                                                                                                         Family                                                      Medicinal part                        Observation       Dose                 Effect                                                  Mechanism of action                                                                                                                                                                                                                                                                                                                                                                                                                    References
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- ------------------------------------- ----------------- -------------------- ------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  Madecassoside             *Centella asiatica*                                                                                                                                                                                                                                                                                                                    Umbelliferae                                                Whole plant                           *In vitro*        10\~100 *μ*M         Antiproliferation of HSFBs\                             Inhibition of HKF migration, F-actin filaments protein, and cytoskeletal protein. Promotion of nuclear shrinkage and mitochondrial membrane depolarization Condensation of chromatin and fragment of nuclei Inhibitory phosphorylation of p38, PI3K, AKT, and cofilin. Activation of caspase-3/caspase-9 Facilitation of Bax mRNA expression and decrease of Bcl-2 and MMP-13 mRNA expression                                          \[[@B15], [@B37]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Promotion of apoptosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Diminishment of scar formation\                                                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Facilitation of wound healing                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Genistein                 *Glycine max*                                                                                                                                                                                                                                                                                                                          Leguminosae                                                 Fruit                                 *In vitro*        25\~100 *μ*g/mL      Anti-proliferation of HSFBs\                            Inhibition of TPKs, increase of caspase-3, and decreases of *α*-SMA and Bcl-2 protein Enhancement of Bax protein Inhibition of types I/III precollagen mRNA expression, down-regulation of collagen I/III mRNA, reduction of PCNA expression, and inhibitory phosphorylation of c-Raf, MEK1/2, ERK1/2, and p38 Induction of morphology changes of apoptosis cells Inhibitory transdifferentiation of fibroblasts into myofibroblasts   \[[@B22]--[@B45]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Suppression of mitosis\                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Promotion of apoptosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  37\~370 *µ*M              Decrease of G~0~-G~1~ phase and increase of G~2~-M phase Increase of C-JUN mRNA expression and decrease of FOS-B mRNA expression in skin keratinocytes Inhibitory mRNA expression of C-JUN and C-FOS in human fibroblasts In keloid fibroblasts, decrease of C-JUN and C-FOS mRNA expression at 37 *µ*M, but enhancement at 370 *µ*M                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Astragaloside IV          *Astragalus Membranaceus*                                                                                                                                                                                                                                                                                                              Leguminosae                                                 Root                                  *In vitro*        12.5\~200 *μ*M       Antiproliferation of HSFBs                              Decrease of collagen I/collagen III and TGF-*β* ~1~ secretion                                                                                                                                                                                                                                                                                                                                                                          \[[@B46]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Tetrandrine               *Stephania tetrandra*                                                                                                                                                                                                                                                                                                                  Menispermaceae                                              Root                                    \                 \                  Antiproliferation of HSFBs                              Inhibition of TGF-*β* ~1~ mRNA transcription, promotion of Smad7 and MMP-1 mRNA expression, and inhibition of Smad2 mRNA expression Decrease of protein expression of collagen I/collagen III, Bcl-2, and MKP-1. Reduction of total collagen volume and S phase, increase of G~0~/G~1~ phase, and prevention of G~0~/G~1~ into G~2~ phase Inhibitory phosphorylation of MEK1/2 and ERK1/2                                              \[[@B47]--[@B50]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *In vitro*        10\~80 *μ*M                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  *In vivo*                 1\~10 mg/L                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

   Local injection\         0.5\~2 mg/L\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
   \                        50 mg/mL, 20 *μ*L\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
   \                         \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
   \                         \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                             \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Aloe-emodin               *Rheum palmatum*                                                                                                                                                                                                                                                                                                                       *Polygonaceae*                                              Root, rhizome                         *In vitro*        20\~80 mg/L          Antiproliferation of HSFBs                              Increase of S phase                                                                                                                                                                                                                                                                                                                                                                                                                    \[[@B51]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  5F                        *Pteris semipinnata*                                                                                                                                                                                                                                                                                                                   Pteridaceae                                                 Whole plant                            \                 \                     \                                                     Blockage of fibroblasts from G~1~ to S phase Decreased protein expression of TGF-*β* ~1~ and type I collagen, increase of caspase-3, and reduction of total collagen and fibroblasts PCNA protein (cyclin) Inhibitory mRNA expression of type I/type III procollagen in SSSF                                                                                                                                                           \[[@B52]--[@B54]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     *In vitro*        20\~80 *μ*g/mL       Antiproliferation of HPS                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  *In vivo*                 10\~40 mg/L                                                                                                                                                                                                                                                                                                                            Reduction of PS volume                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  40\~120 mg/L              Antiproliferation of SSSF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

   \                         \                                                                                                                                                                                                                                                                                                                                      \                                                            \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
   \                          \                                                                                                                                                                                                                                                                                                                                     \                                                           \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Local injection            \                                                                                                                                                                                                                                                                                                                                      \                                                           \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                            20\~80 mg/L\                                                                                                                                                                                                                                                                                                                           Promotion of HPS apoptosis Decrease of hypertrophic index   Reduction of collagen fiber content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Oxymatrine                *Sophora japonica*                                                                                                                                                                                                                                                                                                                     Leguminosae                                                 Root                                  *In vitro*        0.125\~1.0 mg/mL \   Antiproliferation of KFb and HFb\                       Increase of S phase, inhibitory mRNA expression of collagen I/collagen III and reduction of protein expression of Smad3 and ERK~1~ Promotion of Smad7 protein expression Inhibition of p-Smad3 and nuclear translocation of Smad3                                                                                                                                                                                                      \[[@B55], [@B56]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       2 *μ*M                \                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Promotion of KFb apoptosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Ginsenoside Rg3 (G-Rg3)   *Panax ginseng*                                                                                                                                                                                                                                                                                                                        Araliaceae                                                  Root, rhizome                         *In vivo* \       3 mg/mL, 0.1 mL      Inhibition of HS\                                       Increase of protein expression of PCNA, Bax, caspase-3, and Cyt-c Decrease of Bcl-2 protein expression                                                                                                                                                                                                                                                                                                                                 \[[@B27], [@B57]\]
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Local injection                        Decrease of scar tissue fibrosis                                                                                                                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Osthole                   *Cnidium monnieri*                                                                                                                                                                                                                                                                                                                     Apiaceae                                                    Fruit                                 *In vitro*        5\~50 *μ*M           Antiproliferation of HSFBs and Induction of apoptosis   Promotion of Bax mRNA expression and inhibition of Bcl-2 mRNA expression Decreases of TGF-*β* ~1~ protein expression and facilitation of HSFBs shrinkage, chromatin condensation, membrane blebbing, apoptotic body formation, and DNA ladder formation                                                                                                                                                                                \[[@B58]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Antihypertrophic scar displaying phytochemicals widely distributed in medicinal plants.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Phytochemicals                      Observation                              Dose                                                            Effect                                                                                                                                            Mechanism of action                                                                                                                                                                                                                             References
  ----------------------------------- ---------------------------------------- --------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  10-Hydroxycamptothecin (HCPT)       *In vivo*                                0.01\~0.1 mg/mL                                                 Decrease of the area of epidural scar tissue and the number of fibroblasts. Reduction of epidural adhesion and inhibitory proliferation of RESF   Inhibition of topoisomerase I                                                                                                                                                                                                                   \[[@B5]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Angelica naphtha                    *In vitro*                               1\~16 mg/L                                                      Antiproliferation of HSFBs and induction of HSFBs apoptosis                                                                                       Inhibition of G~0~/G~1~ and G~2~/M phases, promotion of S phase, and reduction of collagen protein in fibroblasts                                                                                                                               \[[@B59]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Asiaticoside                        *In vivo* \                              25\~50 mg/mL\                                                   Reduction of scar hyperplasia of HSRE\                                                                                                            Inhibition of the mRNA expression of TGF-*β* ~1~, RhocA, ROCK-I, and CTGF, facilitation of TGF-*β* ~3~ mRNA expression, and decrease of the expression of types I/III collagen and TIMP-1 proteins                                              \[[@B14]--[@B61]\]
                                       \                                       Local injection\                                                Decrease of hypertrophic index\                                                                                                                                                                                                                                                                                                                                                                   
                                        *In vitro*                             25\~1000 *μ*M\                                                  Promotion of keratinocytes migration\                                                                                                                                                                                                                                                                                                                                                             
                                                                               300 *μ*g/mL                                                     Anti-proliferation of HSFBs                                                                                                                                                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Matrine                             *In vitro*                               0.01\~5.00 g/L                                                  Antiproliferation and induction of apoptosis in HSFBs                                                                                             Promotion of G~2~-M phase, inhibition of lactate dehydrogenase and Hyp and enhancement of I/III collagen ratio                                                                                                                                  \[[@B62]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Quercetin                              *In vivo*                             0.05%\~1%, w/o\                                                  Inhibition of scarring in hairless mice                                                                                                          Increase of the protein and mRNA expression of MMP-1 and enhancement of the phosphorylation of JNK and ERK                                                                                                                                      \[[@B38]\]
                                                                               Local Application                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  *In vitro*                          10\~40 *μ*M                               Antiproliferation of HSkF                                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Emodin                              *In vitro*                               50\~200 *μ*g/mL                                                 Antiproliferation of HSFBs                                                                                                                        Inhibition of G~0~/G~1~ phase, increase of intracellular calcium, and decrease of collagen synthesis                                                                                                                                            \[[@B63]--[@B65]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Resveratrol                         *In vitro* \                             25\~400 *μ*M \                                                  Antiproliferation of HSFBs\                                                                                                                       Inhibition of the mRNA expression of type I/type III procollagens                                                                                                                                                                               \[[@B32]\]
                                        *In vivo*                              150\~400 *μ*M Local injections                                   Reduction of hypertrophic scar index                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Tan IIA                             *In vitro*                               20\~80 *μ*g/mL\                                                 Antiproliferation of HSFBs\                                                                                                                       Facilitation of nuclei shrinkage, condensation and fragmentation, blockage of HSFBs from G~1~ to S phases, downregulation of MDA content and XOD activity, increase of T-SOD and GSH-Px activity, and promotion of MMP-1 mRNA expression        \[[@B66]--[@B68]\]
                                                                               0.05\~0.15 mg/mL                                                Induction of HSFBs apoptosis                                                                                                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Curcumin                            *In vitro*                               12.5\~100 *μ*M                                                  Antiproliferation of HSFBs                                                                                                                        Inhibition of procollagen 1 mRNA expression Reduction of hypertrophic index and collagen fiber area density                                                                                                                                     \[[@B69]\]

  *In vivo*                           0.5\~2.0 mM, 0.1 mL/d Local injections                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Dihydroartemisinin                  *In vivo*                                180 mg/kg                                                       Inhibition of HSRE scarring                                                                                                                       Inhibition of collagen fibers and hypertrophic index                                                                                                                                                                                            \[[@B70]\]

  10 mL intragastric administration   Antifibroblast proliferation of HSRE                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Arteannuin                            \                                        \                                                              \                                                                                                                                                Congregation of nuclear chromatin, promotion of calcium concentration, increase of G~0~-G~1~ phase, and reduction of collagen levels and hypertrophic index of HSRE                                                                             \[[@B71]--[@B74]\]
                                      *In vitro*                               0.103\~0.206 mg/mL                                              Antiproliferation of HSFBs                                                                                                                                                                                                                                                                                                                                                                        

  *In vivo* \                         60 mg/mL/2 d                             Decrease of HSRE scarring                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  20 *μ*L local injection\            Antiproliferation of mastocyte\                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Panax notoginseng saponins (PNS)    *In vitro*                               400\~800 *μ*g/mL                                                Antiproliferation of HSFBs                                                                                                                        Inhibition of G~2~-M and G~0~-G~1~ phases, increase of S phase, reduction of the protein expression of TGF-*β* ~1~ and *α*-SMA, and inhibition of intracellular free calcium concentration                                                      \[[@B75], [@B76]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Oleanolic Acid                      *In vivo*                                Topical application of 2.5, 5, and10% for 28 consecutive days   Inhibition of hypertrophic scarring, induction of apoptosis, and reduction of scar elevation index                                                Inhibition of the mRNA expression of TGF-*β* ~1~ mRNA, MMP-1, TIMP-1, and P311. Increase of the mRNA expression of MMP-2, caspase-3, and caspase-9. Reduction of the protein expression of TGF-*β* ~1~ and collagen I/collagen III              \[[@B21]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Hirudin                             *In vitro*                               1\~50 *μ*M                                                      Promotion of apoptosis                                                                                                                            Increase of G~l~ phase and inhibition of S phase Enhancement of the protein expression of MMP-2, MMP-9, and p27, reduction of the protein expression of cyclin E and TGF-*β* ~1~, and inhibition of the mRNA expression of I/III procollagens   \[[@B77]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Xiamenmycin                          \                                         \                                                              \                                                                                                                                                Reduction of CD^4+^ lymphocyte and monocyte/macrophage retention in fibrotic foci Blockage of fibroblast adhesion with monocytes.\                                                                                                              \[[@B78]\]
                                      *In vivo*                                10 mg/kg·d^−1^, intraperitoneal injection for 10 days           Attenuation of hypertrophic scarring and suppression of local inflammation in a mechanical stretch-induced mouse mode                             Inactivation of FAK, p38, and Rho guanosine triphosphatase signaling                                                                                                                                                                            

  *In vitro* \                        5--30 *μ*g/mL\                           Inhibition of proliferation of HSFBs\                                                                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The extracts from medicinal plants displaying anti-hypertrophic scarring.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Extract                 Botanical name                     Family                             Medicinal part   Observation    Dose administration                 Effect                                                                                         Mechanism of action                                                                                                                                                                                               References
  ----------------------- ---------------------------------- ---------------------------------- ---------------- -------------- ----------------------------------- ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  Ethanolic extract       *Calotropis gigantea*              Asclepiadaceae                     Root, bark       *In vivo*      100\~400 mg/kg\                     Increase of wound contraction and decrease of scar area and the time of epithelization         Increase of hydroxyproline and collagen synthesis                                                                                                                                                                 \[[@B6]\]
                                                                                                                                intragastric administration                                                                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethanolic extract       *Daucus carota*                    Apiaceae                           Root             *In vivo*      1, 2, and 4%\                       Decrease of wound area, epithelization period, and scar width. Increase of wound contraction   Increase of hydroxyproline content. Antioxidant and antimicrobial activities                                                                                                                                      \[[@B7]\]
                                                                                                                                epidermal administration                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Methanolic extract      *Pistia stratiotes*                Araceae                            Leave            *In vivo*      5 and 10%\                          Decrease of wound area                                                                         Inhibition of hydroxyl radical scavenging and increase of fibroblast blood vessels and collagen fibers                                                                                                            \[[@B8]\]
                                                                                                                                epidermal administration                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethyl acetate extract   *Gelidium amansii*                 Gelidiaceae                        Whole plant      *In vitro*     5\~10 mg/mL                         Antiproliferation of HSFBs                                                                     Decrease of the protein expression of I/III collagens and TGF-*β* ~1~                                                                                                                                             \[[@B9]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethanolic extract       *Carthamus tinctorius*             Asteraceae                         Flower           *In vitro*     2\~8 *μ*g/mL                        Antiproliferation of HSFBs                                                                     Inhibition of collagen protein synthesis and promotion of fibroblast shrinkage                                                                                                                                    \[[@B79]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Aqueous extract         *Oenothera paradoxa*               Onagraceae                         Seed             *In vitro*     0.1\~10 *μ*g/mL                     Protection of normal dermal fibroblasts                                                        Decrease of LDH and ROS                                                                                                                                                                                           \[[@B80]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Aqueous extract         Cigarette Smoke                    Unknown                            Unknown          *In vitro*     100% saturated solution             Antiproliferation of skin fibroblasts and promotion of cellular senescence                     Inhibition of SOD and GSH-Px and promotion of ROS                                                                                                                                                                 \[[@B12]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethyl acetate extract   *Rheum palmatum*                   Polygonaceae                       Root, rhizome    *In vitro*     25 *μ*g/mL                          Antiproliferation of HSFBs                                                                     Increase of G~0~/G~1~ phase                                                                                                                                                                                       \[[@B39]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Methanol extract        *Broussonetia kazinoki*            Moraceae                           Bark, root       *In vitro*     Unknown                             Inhibition of hyperpigmentation                                                                Reduction of tyrosinase enzyme synthesis                                                                                                                                                                          \[[@B81]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethanol extract         *Scutellaria baicalensis Georgi*   Lamiaceae                          Root             *In vivo*      10 mg/mL epidermal administration   Inhibition of scarring                                                                         Reduction of the protein expression of TGF-*β* ~1~                                                                                                                                                                \[[@B82]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Aqueous extract         *Allium cepa*                      Liliaceae                          Corm               *In vivo*    1\~2.5%, v/v\                       Suppression of scarring in hairless mice                                                       Upregulation of MMP-1 and type I collagen expression                                                                                                                                                              \[[@B38]\]
                                                                                                                                local application                                                                                                                                                                                                                                                                                                                                    

    *In vitro*            1\~2.5%, v/v                       Antiproliferation of fibroblasts                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Aqueous extract         *Tamarindus indica*                Fabaceae                           Bark, leave      *In vivo*      Unknown                             Anti-inflammation                                                                              Elimination of death cells and necrotic tissues                                                                                                                                                                   \[[@B40]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ethanol extract         *Aneilema keisak*                  Commelinaceae                      Whole plant      *In vitro*     40 *μ*g/mL                          Decrease of scarring                                                                           Inhibition of TGF-*β* ~1~-dependent signalling by reducing Smad2 protein. Reduction of various hKF pathological responses, including hyperplastic growth, collagen production, and migration without DNA damage   \[[@B83]\]
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The preparations from different medicinal plants with antihypertrophic scar activity.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Preparations                 Botanical name                                                              Family        Medicinal part   Preparation                                     Vehicle             Delivery system                             Observation                  Effect                                                                                                                                                        Mechanism of action                                                                                                                                       References
  ---------------------------- --------------------------------------------------------------------------- ------------- ---------------- ----------------------------------------------- ------------------- ------------------------------------------- ---------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------
  Hydroxycamptothecin (HCPT)   *Camptotheca acuminata*                                                     Nyssaceae     Fruit, leave     Liposome-encapsulated 10-HCPT                   Liposome            Liposome-encapsulated                       *In vivo* \                  Antiproliferation of fibroblasts and reduction of epidural adhesion                                                                                           Decrease of epidural scar area and fibroblast number in the epidural scar tissue                                                                          \[[@B23], [@B25]\]
                                                                                                                                                                                                                                                          Implant                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Oxymatrine (OMT)             *Sophora flavescens*, *Sophora alopecuroides*, and *Sophora subprostrata*   Leguminosae   Unknown          Oxymatrine-phospholipid complex (OMT-PLC)       Phospholipid        Microemulsion                               *In vitro*  \                Antiproliferation of fibroblasts                                                                                                                              Improvement of OMT skin permeability and increase of retention ratio of OMT in skin.                                                                      \[[@B24]\]
                                                                                                                                                                                                                                                          *In vivo* \                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                          topical delivery                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Astragaloside IV             *Astragalus* \                                                              Leguminosae   Root             Solid lipid\                                    Lipid hydrogel      Solid lipid nanoparticle, hydrogel          *In vitro* \                 Enhancement of keratinocytes migration and proliferation Increase of drug uptake in fibroblasts Promotion of wound healing and inhibition of scar formation   Caveolae endocytosis pathway. Increase of wound closure rate and angiogenesis Improvement of collagen regular organization                                \[[@B26]\]
                               *membranaceus*                                                                                             nanoparticle-enriched hydrogel (SLN-gel)                                                                        *In vivo,*topical delivery                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Ginsenoside Rg3 (G-Rg3)      *Red Panax ginseng*                                                         Araliaceae    Root, rhizome    Ginsenoside Rg3/Poly (l-lactide) (G-Rg3/PLLA)   Electrospun poly\   Electrospun fibrous scaffolds, nanofibers   *In vitro* \                 Inhibition of fibroblast cell growth, antiproliferation of fibroblasts, and prevention of scar formation                                                      Improvement of dermis layer thickness, collagen fibers, and microvessels                                                                                  \[[@B27]\]
                                                                                                                                                                                          (L-lactide) fiber                                               *In vivo*                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Centella asiatica extract    *Centella asiatica*                                                         Apiaceae      Whole plant      *Centella asiatica* extract capsule             Capsule             Nothing                                     *In vivo*                    Inhibition of tissue overgrowth, reduction of scar and keloid, and anti-inflammation                                                                          Promotion of collagen I protein expression, collagen remodeling, and glycosaminoglycan synthesis Enhancement of collagen and acidic mucopolysaccharides   \[[@B41]\]
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Summary of antiscarring mechanisms of medicinal plant components.

  Mechanism                                                               Medicinal plant component                                             
  ----------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  MAPK pathway                                                            Inhibition of p-p38 signaling                                         Madecassoside, Genistein, and Xiamenmycin
  Inhibition of p-ERK1/2 signaling                                        Genistein, Tetrandrine, Cryptotanshinone, and Quercetin               
  Inhibition of p-JNK signaling                                           Quercetin                                                             
  PI3K/AKT signaling                                                                                                                            Madecassoside
  Mitochondrial-dependent pathway                                         Increase of Bax                                                       Madecassoside, Genistein, Ginsenoside Rg3, and Osthole
  Decrease of Bcl-2                                                       Madecassoside, Genistein, Tetrandrine, Ginsenoside Rg3, and Osthole   
  Increase of cytoplasm Cyt-c                                             Ginsenoside Rg3                                                       
  Cell cycle                                                              Decrease of G~0~-G~1~ phase                                           Genistein, Angelica naphtha, Emodin, and Panax notoginseng saponins
  Increase of G~2~-M                                                      Genistein                                                             
  Decrease of S phase                                                     10-Hydroxycamptothecin, Tetrandrine, Aloe emodin, and Hirudin         
  Prevention from G~0~/G~1~ into G~2~ phase                               Tetrandrine                                                           
  RhoA/ROCK-I signal pathway                                              Inhibitory secretion of RhocA, ROCK-I, and CTGF                       Xiamenmycin
  VEGF signal pathway                                                                                                                           Cryptotanshinone
  FAK signal pathway                                                                                                                            Cryptotanshinone, Xiamenmycin
  TGF-*β*/Smad signaling pathway                                                                                                                Oxymatrine
  Downregulation of collagen I/III expression                                                                                                   Genistein, Astragaloside IV, Tetrandrine, Resveratrol, 5F, Curcumin, Oleanolic Acid, and Hirudin
  Decrease of *α*-SMA                                                                                                                           Genistein, Panax notoginseng saponins
  Activation of caspases                                                  Activation of caspase-3                                               Madecassoside, Genistein, 5F, Cryptotanshinone, Oleanolic Acid, and Ginsenoside Rg3
  Activation of caspase-9                                                 Madecassoside, Oleanolic Acid                                         
  Suppression of TPK activation                                                                                                                 Kazinol F
  Inhibition of topoisomerase I                                                                                                                 10-Hydroxycamptothecin
  Decrease of TGF-*β* ~1~ secretion                                                                                                             Tetrandrine, Panax notoginseng saponins, Osthole, and Hirudin
  Inhibition of TGF-*β* ~1~ transcription                                                                                                       Astragaloside IV, Oleanolic Acid
  Downregulation of TIMP-l expression                                                                                                           Oleanolic Acid
  Reduction of LDH and increase of the ratio of collagen I/collagen III                                                                         Matrine
  Increase of T-SOD and GSH-Px activity                                                                                                         Tan IIA
  MMP                                                                     Enhancement of MMP-1                                                  Tetrandrine, Tan IIA, and Oleanolic Acid
  Enhancement of MMP-2 and MMP-9                                          Hirudin                                                               
  Enhancement of MMP-13                                                   Madecassoside                                                         
  Increase of intracellular calcium                                                                                                             Emodin, Arteannuin

###### 

Summary of antiscarring mechanisms of plant extracts.

  Mechanism                                         Medicinal plants extract
  ------------------------------------------------- ------------------------------------------------------
  Cell cycle                                         
   Increase of G~0~-G~1~ phase                      Rhubarb
  Collagen                                           
   Downregulation of collagen l expression          *Gelidium amansii*
   Downregulation of collagen III expression        *Gelidium amansii*, *Scutellaria baicalensis Georgi*
   Enhancement of collagen synthesis                *Calotropis gigantea*
   Inhibition of collagen synthesis                 *Carthamus tinctorius*
   Promotion of collagen I                          Onion
  MMP                                                
   Enhancement of MMP-1                             *Neonauclea reticulata*, Onion
   Increase of MMP-3 and MMP-9                      *Neonauclea reticulata*
  Elimination of hydroxyl radical                   *Pistia stratiotes*
  Decrease of LDH                                   *Oenothera paradoxa*
  Decrease of ROS                                   *Oenothera paradoxa*, *Neonauclea reticulata*
  Increase of ROS and reduction of SOD and GSH-Px   *Cigarette Smoke*
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